June 22, 2009
1 min read
Save

False positive rates varied among diagnostic mammography facilities

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Variability in the results of diagnostic mammograms was found to exist among facilities, according to the results of a cross-sectional survey of facilities in the Breast Cancer Surveillance Consortium. Specifically, the rate of false positives was almost 50% higher among facilities who reported recommending additional tests out of concern about malpractice.

Researchers conducted a survey of 45 facilities that performed diagnostic mammography. Facilities were surveyed about their structure, organization and interpretive processes.

From January 1998 to December 2005, measurements of false-positive rate, sensitivity, and likelihood of cancer among women referred for biopsy were taken. Thirty-two facilities performed diagnostic mammography; 28,100 diagnostic mammograms were performed. One hundred eighteen radiologists at the participating facilities completed a survey examining radiologist characteristics and perceptions.

For facilities, the overall mean false-positive rate was 6.5% (95% CI, 5.5%-7.4%), and mean sensitivity was 73.5% (95% CI, 67.1%-79.9%). Positive predictive value of biopsy recommendation was 33.8% (95% CI, 29.1%-38.5%).

In an unadjusted analysis, variability was observed across facilities for sensitivity (P=.006), false-positive rate (P<.001) and positive predictive value of biopsy recommendation (P<.001). However, when adjusted for patient and radiologist characteristics, variability in performance also persisted for false-positive rates (P<.001).

Facilities reporting that concerns about malpractice greatly increased recommendations for additional tests at the facility were linked to even higher false-positive rates (OR=1.48; 95% CI, 1.09-2.01).

Jackson SL. J Natl Cancer Inst. 2009;101:814-827.

More In the Journals summaries>>